Dr. Guillaume Kellermann

Presentation Time and Location
on 27th, during Rising Biotech Stars Session (from 14.00 to 16.00)
Company Profile
Telomium is a biotechnology company developing a therapeutic product for cancer immunotherapy based on telomerase. Telomerase is the enzyme that controls the potential of cellular proliferation, and which is reactivated in 90% of human cancers (Nobel Prize 2009). So far, a major limitation in the development of an effective telomerase immunotherapy has been the technical impossibility to produce significant amount of telomerase protein, but recently a breakthrough system now allows its large-scale production (PMID: 25958399). Telomium implements this new technology which furthermore supports the preparation of a cancer vaccine of a completely new class in the pharmacopoeia: a ribonucleoprotein vaccine, which has the special ability to reproduce the mechanisms operating in autoimmunity that breaks immune tolerance. This self-adjuvanted and self-vectored telomerase ribonucleoprotein vaccine is prepared from a patented, safe, competitive and scalable yeast-based technology. By inducing a full activation of the immune system against cells producing telomerase (=the cancer cells in an adult body), our product has the ability to induce an autoimmune reaction targeted against any form of cancer, without causing significant side effects. Given the almost universal presence of telomerase in human cancers our product has the potential to extend the efficiency of immune checkpoint-inhibitors from the current minority to a majority of patients.
Company Type
Keywords

cancer, immunotherapy, vaccine, telomerase

Year Founded
2016
Pipeline Product 1: Name/Stage
Cancer Vaccine based on Telomerase (preclinical research)
Dr. Guillaume Kellermann
Telomium, SAS
Founder & CEO 
Conference attendance

Dr. Stefan Kleiser

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Website
www.oxyprem.com
Oxyprem
Co-Founder 
Conference attendance

Kyriakos Kokkoris PhD

Presentation Time and Location
on 25th, during Rising European Stars Session (from 16.15 to 17.15)
Company Website
http://karmagenes.co
Company Profile
At Karmagenes, we do behavioral genetic and psychological analysis to improve people’s personal and professional life. Karmagenes SA is a Swiss-based startup and its scientific team has developed proprietary algorithms that a) provide an unbiased view of genetic potential through DNA-based personality test, b) assess current personality through KG5+ psychological tool and c) offer custom advice through in-house psychologist regarding career orientation, partnership and wellbeing.

Since more than 450mio people have a bad mental being affecting their capacity ‘’to work and to love’’, our next step is to apply our technology to a life coaching app combining psychological and genetic data analysis coupled with artificial intelligence. 

At your fingertip, you will have access to our existing network of coaches and specialists who can help you improve your overall wellbeing by understanding the real you.

Company Type
Other Sector
DTC Genetic Testing
Keywords

DNA, PSYCHOLOGY, NATURE, NURTURE, COACHING, BIOTECH, GENETIC TEST, ASSESSMENT, INNOVATION, PERSONALISED, FUTURE

Kyriakos Kokkoris PhD
Karmagenes SA
CEO 
Conference attendance
Biography

https://www.linkedin.com/in/kyriakoskokkoris/